Skip to content

Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease

Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02646488
Enrollment
276
Registered
2016-01-05
Start date
2015-08-31
Completion date
2019-04-01
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, High Blood Pressure

Keywords

cholesterol, smoking, aspirin, chronic care model

Brief summary

The primary purpose of this study is to evaluate the effectiveness of practice facilitation as a quality improvement strategy for implementing the Million Hearts' ABCS treatment guidelines for reducing cardiovascular disease (CVD) among high-risk patients who receive care in primary care practices in New York City. The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S). The long-term goal is to create a robust infrastructure to disseminate and implement evidence based practice guidelines (EBPG) findings in primary care practices and improve practices' capacity to receive and implement other EBPG findings in the future.

Interventions

BEHAVIORALFollow Up Post Intervention 21 Months
BEHAVIORALFollow Up Post Intervention 24 Months
BEHAVIORALFollow Up Post Intervention 27 Months
BEHAVIORALFollow Up Post Intervention 30 Months
BEHAVIORALFollow Up Post Intervention 33 Months
BEHAVIORALStandard Care Regimen 15 Months
BEHAVIORALStandard Care Regimen 18 Months
BEHAVIORALStandard Care Regimen 21 Months
BEHAVIORALStandard Care Regimen 24 Months
BEHAVIORALStandard Care Regimen 27 Months
BEHAVIORALMillion Hearts ABCS 6 Months

The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S).

BEHAVIORALMillion Hearts ABCS 9 Months

The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S).

BEHAVIORALMillion Hearts ABCS 12 Months

The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S).

BEHAVIORALMillion Hearts ABCS 15 Months

The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S).

BEHAVIORALStandard Care Regimen 9 Months
BEHAVIORALStandard Care Regimen 12 Months

Sponsors

Agency for Healthcare Research and Quality (AHRQ)
CollaboratorFED
NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Provider and staff eligibility inclusion criteria. * Eligibility includes working full or part time at the study site. Stakeholder eligibility inclusion criteria. * Steering committee members or other key stakeholder from the following groups: Health Plan Chief Medical Officer, State health officials in the Chronic Disease Program, and leadership from relevant national associations (American Heart Association), members of Advisory Board of CHCANYS (these are physician leaders). Patient eligibility inclusion criteria: * at least one of the ABCS risk factors for CVD (i.e., hypertension, hyperlipidemia, eligible for aspirin and/or is a current smoker) * must have received care at the clinic for at least 12 months * Patients eligible for aspirin are those with a documented ICD-9 code for ischemic vascular disease in the last 12 months. Similarly, patients with a diagnosis of hypertension and/or hyperlipidemia will have a documented ICD-9 code for the targeted risk factor * Smokers will be identified by a documented ICD-9 code, prescription for a cessation medication in the last 12 months or documentation in the chart (e.g. meaningful use measure) during the last 12 months (see outcome measures)

Design outcomes

Primary

MeasureTime frame
Percentage of patients with documented use of aspirin or other antithrombotic.18 Months
Percentage of patients who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately controlled18 Months
Percentage of patients who had a fasting lipoprotein (LDL) test performed and whose risk-stratified fasting LDL is at or below the recommended low density lipoprotein (LDL) goal18 Months
Change in the percentage of patients who had a low density lipoprotein (LDL) test who are prescribed a recommended dose of statin based on risk status if indicated.18 Months
Percentage of patients who were screened about tobacco use one or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco user.24 Months

Secondary

MeasureTime frame
Percentage of patients aged 18 through 85 years of age who had a diagnosis of hypertension (HTN) who are prescribed recommended medications, if indicated.18 Months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026